Short interest in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) increased during the last reporting period, rising from 8.48M to 8.71M. This put 6.13% of the company's publicly available shares short.

Short interest for Aurinia Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Aurinia Pharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.63M shares traded per day, it would take 5.33 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.